校正:CD80在免疫疗法药物开发方面的研究进展
Lanying Li1, Lei Yang1, DePeng Jiang1
1Department of Respiratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Frontiers in immunology
|December 20, 2024
概括
本研究详细说明了对先前发表的文章的纠正. 更新的信息确保科学记录是准确的,用于未来的研究和参考.
科学领域:
- 免疫学 免疫学 免疫学
- 科学出版科学出版
背景情况:
- 确保科学文献的准确性对于研究完整性至关重要.
- 修正是必要的,以保持公布结果的可靠性.
研究的目的:
- 为特定的文章提供纠正.
- 更新数字物体标识符 (DOI) 以准确引用.
主要方法:
- 发出了一份正式的纠正通知.
- 这篇文章的 DOI 被更新了.
主要成果:
- 原文的DOI已经被纠正.
- 这确保了研究的正确归因和检索.
结论:
- 准确的DOI对科学界至关重要.
- 这次纠正符合科学传播的标准.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475